AU2072088A - Agent containing salicylic acid for treating lepidosis - Google Patents

Agent containing salicylic acid for treating lepidosis

Info

Publication number
AU2072088A
AU2072088A AU20720/88A AU2072088A AU2072088A AU 2072088 A AU2072088 A AU 2072088A AU 20720/88 A AU20720/88 A AU 20720/88A AU 2072088 A AU2072088 A AU 2072088A AU 2072088 A AU2072088 A AU 2072088A
Authority
AU
Australia
Prior art keywords
salicylic acid
lepidosis
treating
agent containing
containing salicylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20720/88A
Inventor
Konrad Minninger
Rainer Oberhagemann
David Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2072088A publication Critical patent/AU2072088A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)

Abstract

An agent containing salicylic acid for treating lepidosis in human and veterinary medicine contains 4 to 10 wt. % of salicylic acid, 1 to 7 wt. % of an aliphatic 1,2-diol, and 83 to 95 wt. % of a fatty oil, where the total weight of the agent = 100.
AU20720/88A 1987-07-25 1988-07-19 Agent containing salicylic acid for treating lepidosis Abandoned AU2072088A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3724691 1987-07-25
DE3724691A DE3724691C2 (en) 1987-07-25 1987-07-25 Pharmaceutical agent for the local therapy of flaking skin diseases

Publications (1)

Publication Number Publication Date
AU2072088A true AU2072088A (en) 1989-03-01

Family

ID=6332361

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20720/88A Abandoned AU2072088A (en) 1987-07-25 1988-07-19 Agent containing salicylic acid for treating lepidosis

Country Status (9)

Country Link
EP (1) EP0325628B1 (en)
JP (1) JPH02500106A (en)
AT (1) ATE69550T1 (en)
AU (1) AU2072088A (en)
DE (2) DE3724691C2 (en)
DK (1) DK173547B1 (en)
FI (1) FI94314C (en)
NO (1) NO175885C (en)
WO (1) WO1989000853A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001303B (en) * 1989-01-23 1993-07-30 Wolff Chem Pharm Gmbh Method for preparation of a means that contains salicyloxyd against scaling sick
WO1990008547A1 (en) * 1989-01-25 1990-08-09 Dr. August Wolff Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Preparation containing salicylic acid for treating desquamative skin diseases
GB9223034D0 (en) * 1992-11-03 1992-12-16 Surtech Int Ltd Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis
SE9403541L (en) * 1994-10-14 1996-04-15 Sven Moberg Antimicrobial composition
US5736580A (en) * 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
WO1998011882A1 (en) * 1996-09-18 1998-03-26 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
DE10205193A1 (en) * 2002-02-08 2003-08-21 Beiersdorf Ag Cleaning preparations containing diol
DE10341179A1 (en) † 2003-09-06 2005-03-31 Beiersdorf Ag Cosmetic or dermatological preparations containing synergistic combination of alpha- or beta-hydroxyacid and alkanediol, useful for combating acne and/or Propionibacterium acnes infection
JP6339940B2 (en) 2011-12-20 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー．リミテッド Topical oil composition for the treatment of fungal infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE762726C (en) * 1942-05-02 1952-09-15 Hydrierwerke A G Deutsche Solvent or solubilizer for salicylic acid
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
FR2585575B1 (en) * 1985-08-01 1989-03-03 Pf Medicament PHARMACEUTICAL COMPOSITIONS WITH KERATOLYTIC ACTIVITY IN GEL FORM COMPRISING HYDROALCOHOLIC SALICYLIC ACID

Also Published As

Publication number Publication date
FI94314B (en) 1995-05-15
WO1989000853A1 (en) 1989-02-09
DK137589D0 (en) 1989-03-21
NO891220D0 (en) 1989-03-20
FI94314C (en) 1995-08-25
DK173547B1 (en) 2001-02-19
DE3724691C2 (en) 1999-03-18
ATE69550T1 (en) 1991-12-15
EP0325628B1 (en) 1991-11-21
DK137589A (en) 1989-05-19
NO175885B (en) 1994-09-19
DE3866344D1 (en) 1992-01-02
NO175885C (en) 1994-12-28
FI891357A (en) 1989-03-22
DE3724691A1 (en) 1989-02-02
NO891220L (en) 1989-03-20
JPH02500106A (en) 1990-01-18
EP0325628A1 (en) 1989-08-02
FI891357A0 (en) 1989-03-22

Similar Documents

Publication Publication Date Title
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
ZA885192B (en) Pharmaceutical preparations
MY101791A (en) New benzimidazole derivatives
NL186062C (en) SOLUTION OF AT LEAST AN ESSENTIAL FATTY ACID OR A MIXTURE THEREOF IN A VEGETABLE OIL AND A COSMETIC PREPARATION CONTAINING SUCH A SOLUTION.
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
GB8319073D0 (en) Fatty acid compositions
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
MY104412A (en) Acne treatment.
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
KR970009581B1 (en) Composition for topical use containing depolymerized deoxyribonucleic acids in the skin and body cosmetic treathent
IL86395A0 (en) Pharmaceutical compositions containing flunarizine
JPS6434909A (en) Cosmetic
ZA796154B (en) Tablets
MY103079A (en) New ophtalmological composition of matter
ZA784083B (en) Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
ES2009569A6 (en) Compositions acting on the heart and cardio-vascular system
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
GB2087888B (en) New bicyclo(2.2.1)heptane derivatives and their use as plant growth regulants
DE3564581D1 (en) Glycosaminoglycans for use in cosmetology
DE3850310D1 (en) PTH modifications and therapeutic compositions containing and consisting of them.
DK138191D0 (en) SALICYLIC ACID CONTAINER FOR TREATMENT OF HAZARDOUS SKIN DISEASES
ES8300475A1 (en) Modified allergens.
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
IT1211765B (en) Water-soluble ubidecarenone derivs., and cosmetic compsns.